ENTITY

Organon & (OGN US)

10
Analysis
Health Care • United States
Organon & Co. operates as a pharmaceutical company. The Company develops and produces medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergies, and asthma. Organon & Co serves customers worldwide.
more
Exchange Announcement • 31 Jul 2026 20:23

Current Report (Form 8-K | Period ending 2026-07-31)

Exchange Announcement • 31 Jul 2026 20:06

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 24 Jul 2026 05:13

Current Report (Form 8-K | Period ending 2026-07-23)

Exchange Announcement • 18 Jul 2026 04:01

Current Report (Form 8-K | Period ending 2026-07-17)

Exchange Announcement • 17 Jun 2026 18:04

DEFM14A | Definitive proxy statement relating to merger or acquisition

x